¹û¶³Ö±²¥ÊÓƵ

Trained as a medical doctor in the UK, I’ve been working almost exclusively on malaria since 1995. I lived in Tanzania for 10 years and worked on a variety of descriptive epidemiology studies, clinical intervention trials and a pilot implementation programme. I was then based at LSHTM in London for 10 years, teaching and overseeing various malaria research and capacity strengthening activities, before spending 5 years at the Global Malaria Programme in WHO, Switzerland. There I supported the and the development of the first WHO recommendation for use of a malaria vaccine. I led the process to update existing and develop new malaria chemoprevention recommendations, now incorporated in the , and helped shape the development of new products for malaria prevention through the development of Preferred Product Characteristics for vaccines, chemoprevention and monoclonal antibodies.

My first degrees are in clinical science and medicine from the University of London, followed by a DTM&H from Liverpool, MRCP in London and PhD from the University of Barcelona, Spain. I was based at the Ifakara Health Institute, Tanzania, 1995-2001 and 2004-2007, and joined the School in 2003 to help build the IPTi Consortium. I was based in London 2007-2016, then WHO, Geneva 2016-2022 and returned to LSHTM in May 2022. Since May 2023 I have been working with BioNTech to support their portfolio of Global Health activities.